StockData
Danaher Corp logo

Danaher Corp

DHRNYSEIndustrial Instruments For Measurement, Display, and ControlFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 26, 2026Last filing: 10-Q on Jul 21, 2026Score 12/3025% above fair value
$227.97−4.26 (-1.83%)

Close on Nov 2, 2026Market cap $160.26BP/E 40.5Yield –

Danaher Biotechnology by Quarter

Biotechnology — Intangibles Amortization % of Segment Sales (MD&A) (%)

QuarterlyAnnual

Danaher Biotechnology: 12.6% in Q3 2026, down 0.2 pts from a year earlier.

Latest, Q3 2026
12.6%
Period ended Sep 30, 2026
Change on a year earlier
-0.2 pts
12.8% in Q3 2025
History
15 quarters
Since Q1 2022
Sources
12
Documents cited below

Where the Q3 2026 figure comes from

Source: Danaher SEC 10-Q (2026Q3, filed 2026-10-21) ↗

Reported for Q1, Q2, Q3 (10-Q) and full year (10-K), with no standalone Q4 reported.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedBiotechnology — Intangibles Amortization % of Segment Sales (MD&A) (%)Year on yearSource
Q3 2026Sep 30, 202612.6%-0.2 ptsDanaher SEC 10-Q (2026Q3, filed 2026-10-21) ↗
Q2 2026Jun 30, 202612.0%-0.3 ptsDanaher SEC 10-Q (2026Q2, filed 2026-07-21) ↗
Q1 2026Mar 31, 202613.0%-0.2 ptsDanaher SEC 10-Q (2026Q1, filed 2026-04-21) ↗
Q3 2025Sep 30, 202512.8%-0.4 ptsDanaher SEC 10-Q (2025Q3, filed 2025-10-21) ↗
Q2 2025Jun 30, 202512.3%-0.2 ptsDanaher SEC 10-Q (2025Q2, filed 2025-07-22) ↗
Q1 2025Mar 31, 202513.2%-1.1 ptsDanaher SEC 10-Q (2025Q1, filed 2025-04-22) ↗
Q3 2024Sep 30, 202413.2%+0.3 ptsDanaher SEC 10-Q (2024Q3, filed 2024-10-22) ↗
Q2 2024Jun 30, 202412.5%+0.9 ptsDanaher SEC 10-Q (2024Q2, filed 2024-07-23) ↗
Q1 2024Mar 31, 202414.3%+2.7 ptsDanaher SEC 10-Q (2024Q1, filed 2024-04-23) ↗
Q3 2023Sep 30, 202312.9%+3.3 ptsDanaher SEC 10-Q (2023Q3, filed 2023-10-24) ↗
Q2 2023Jun 30, 202311.6%+2.6 ptsDanaher SEC 10-Q (2023Q2, filed 2023-07-25) ↗
Q1 2023Mar 31, 202311.6%+1.9 ptsDanaher SEC 10-Q (2023Q1, filed 2023-04-25) ↗
Q3 2022Sep 30, 20229.6%–Danaher SEC 10-Q (2023Q3, filed 2023-10-24) ↗
Q2 2022Jun 30, 20229.0%–Danaher SEC 10-Q (2023Q2, filed 2023-07-25) ↗
Q1 2022Mar 31, 20229.7%–Danaher SEC 10-Q (2023Q1, filed 2023-04-25) ↗

Cite this data

StockData. (2026). Danaher Biotechnology (%), quarterly Q1 2022–Q3 2026 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/mda-amort-pct-sales-biotech

See every metric in the Danaher KPI table. Data updated Nov 2, 2026.